Skip to main content

Year: 2025

Diana Shipping Inc. Announces Time Charter Contract for m/v Medusa With Cargill

ATHENS, Greece, March 12, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned subsidiary, it has entered into a time charter contract with Cargill International SA, Geneva, for one of its Kamsarmax dry bulk vessels, the m/v Medusa. The gross charter rate is US$13,000 per day, minus a 4.75% commission paid to third parties, for a period until minimum May 15, 2026 up to maximum July 15, 2026. The charter is expected to commence on March 15, 2025. The “Medusa” is an 82,194 dwt Kamsarmax dry bulk vessel built in 2010. The employment of “Medusa” is anticipated to generate approximately US$5.46 million of gross revenue for the minimum scheduled period of the time...

Continue reading

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

GAITHERSBURG, Md., March 12, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today the pricing of an underwritten public offering of 19,166,667 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.30 per share (the “Offering”). The aggregate gross proceeds to Shuttle Pharma from the Offering are expected to be approximately $5.75 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Shuttle Pharma. The Offering is expected to close on March 13, 2025, subject to the satisfaction of customary...

Continue reading

Coherent Launches Industry-First 793nm Pump Laser Diode with Record 28W Power and 97% Polarization Purity

PITTSBURGH, March 12, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), the leader in advanced laser technology, is proud to announce the launch of its groundbreaking 793nm pump laser diode, setting a new industry standard with an impressive 28W of reliable power and 97% polarization purity. This innovative product offers unmatched performance and cost-efficiency, unlocking new possibilities for applications in the rapidly growing Thulium fiber laser market. A Game-Changer in Thulium Fiber Laser TechnologyThe increasing adoption of Thulium fiber lasers in medical applications has transformed patient care, offering a safer, more comfortable treatment experience with faster recovery times. With the market for Thulium fiber lasers projected to grow significantly, the new 793nm chip from Coherent is poised to meet the growing demand...

Continue reading

Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial

Encouraging Safety Profile Supports Progression Toward First Dual-Administration of Selective A2A and A2B Antagonists in Patients DOVER, Del., March 12, 2025 (GLOBE NEWSWIRE) — Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, today announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a highly selective A2A antagonist, within its ADPORT-601 Phase 1b clinical trial. Portage had previously paused this trial due to funding concerns; this resumption of the trial underscores the encouraging findings observed in earlier cohorts. After the completion of the PORT-6 arm of the ADPORT-601 study, Portage will evaluate the continuation of the study into its PORT-7 (potent and...

Continue reading

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, and Rocketvax Ltd, one of Switzerland’s next-generation vaccine companies and a member of the Swiss Rockets Ltd family of companies, today announced entry into an agreement for Emergent’s strategic financial investment into Swiss Rockets Ltd, the parent company of Rocketvax Ltd, to support research, infrastructure development, and the expansion of Swiss Rockets’ innovative biotechnology portfolio. This endeavor underscores Emergent’s commitment to supporting Swiss Rockets’ broader mission of pioneering breakthrough medical technologies. In addition to the investment, the parties intend to form a strategic...

Continue reading

BEN Supports California’s AI Data Privacy Bill

WILMINGTON, Del., March 12, 2025 (GLOBE NEWSWIRE) — Brand Engagement Network Inc. (BEN) (NASDAQ: BNAI), an innovator in AI-driven customer engagement solutions, has announced its support for California Assembly Member Carl DeMaio’s proposed AI data privacy legislation. This bill, which aims to secure the privacy of California residents, would require businesses to obtain explicit consent before sharing or storing user data outside the United States. As AI adoption accelerates across industries, the need for robust data protection has never been more critical. BEN recognizes the importance of securing user data and supports DeMaio’s initiative as a vital step in advancing privacy protections in the AI space. “Data privacy is a fundamental right, and it is crucial that we hold ourselves accountable in developing AI technologies,”...

Continue reading

Vera Bradley Announces Fourth Quarter Fiscal Year 2025 Results

Consolidated net revenues totaled $372.0 million for the fiscal year Financial condition remains strong with no debt and approximately $30 million in cash Management provides guidance for fiscal year 2026 Outlook anticipates fiscal 2026 year-end cash balance increasing to approximately $40 million FORT WAYNE, Ind., March 12, 2025 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced its financial results for the fourth quarter and fiscal year ended February 1, 2025 (“Fiscal 2025”). In this release, Vera Bradley, Inc. or “the Company” refers to the entire enterprise and includes both the Vera Bradley and Pura Vida brands. Vera Bradley on a stand-alone basis refers to the Vera Bradley brand. Fourth Quarter and Fiscal Year-End Comments Jackie Ardrey, Chief Executive Officer commented, “The fourth quarter...

Continue reading

NANO Nuclear Energy Expands its Regulatory and Safety Expertise with the Addition of Seasoned Professional Andrew Steer, Ph.D. as Head of Regulatory Engagement

Figure 1NANO Nuclear Energy Inc. Appoints Dr. Andrew Steer as Head of Regulatory Engagement.New York, N.Y., March 12, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced the addition of Andrew Steer, Ph.D., a recognized specialist in nuclear safety case development as its Head of Regulatory Engagement. Dr. Andrew Steer is a nuclear safety case and regulatory engagement expert with over 18 years of experience in the nuclear industry. Until recently, Dr. Steer served as Head of Licensing and Regulation at MoltexFLEX, a British nuclear energy company developing advanced small modular molten salt reactors. Dr. Steer led the strategy, scope and development of the...

Continue reading

Ocean Power Technologies Announces Binding Letter of Intent to Deploy AI-Capable PowerBuoy for a Major International Defense Contractor

MONROE TOWNSHIP, N.J., March 12, 2025 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it received a binding letter of intent to deploy a PowerBuoy® for an undisclosed customer to demonstrate the survivability and suitability of the system for certain multidomain defense and security applications in extreme sea conditions. This follows the signing of a teaming agreement with a major international defense contractor last year to provide its Merrows™ suite of solutions with a focus on certain geographic regions. Mr. Philipp Stratmann, CEO and President of Ocean Power Technologies, expressed enthusiasm about the deployment, stating, “We are excited to advance...

Continue reading

SAIC and Defense Unicorns Partner to Transform Software Delivery for the Department of Defense

Integration of UDS into SAIC ecosystem accelerates delivery of industry-leading software capabilities and expands offerings for defense customers RESTON, Va., March 12, 2025 (GLOBE NEWSWIRE) — Science Applications International Corp. (NASDAQ: SAIC) and Defense Unicorns announced a strategic partnership to increase the delivery of secure, scalable and mission-critical software capabilities for the Department of Defense (DoD). Through this collaboration, SAIC will integrate Defense Unicorns’ Unicorn Delivery Service (UDS) into its existing, robust software delivery ecosystem, streamlining how SAIC deploys and maintains applications across cloud, on-premises and tactical edge environments – ultimately improving operational readiness for today’s warfighters. The DoD relies on software to support mission-critical operations across all...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.